Intellia Therapeutics Inc... (NTLA)
NASDAQ: NTLA
· Real-Time Price · USD
11.01
0.02 (0.18%)
At close: Aug 18, 2025, 10:38 AM
0.18% (1D)
| Bid | 11 |
| Market Cap | 1.18B |
| Revenue (ttm) | 45.57M |
| Net Income (ttm) | -525.91M |
| EPS (ttm) | -4.69 |
| PE Ratio (ttm) | -2.35 |
| Forward PE | -2.79 |
| Analyst | Buy |
| Ask | 11.01 |
| Volume | 944,461 |
| Avg. Volume (20D) | 5,199,496 |
| Open | 11.00 |
| Previous Close | 10.99 |
| Day's Range | 10.86 - 11.09 |
| 52-Week Range | 5.90 - 24.16 |
| Beta | 2.31 |
About NTLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NTLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NTLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Intellia Therapeutics Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-22.88%
Intellia Therapeutics shares are trading lower aft...
Unlock content with
Pro Subscription
3 months ago
+13.58%
Intellia Therapeutics shares are trading higher after the company reported better-than-expecpted Q1 financial results.
